These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 33456721)

  • 1. Recent applications and strategies in nanotechnology for lung diseases.
    Zhong W; Zhang X; Zeng Y; Lin D; Wu J
    Nano Res; 2021; 14(7):2067-2089. PubMed ID: 33456721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology in pulmonary medicine.
    Doroudian M; O' Neill A; Mac Loughlin R; Prina-Mello A; Volkov Y; Donnelly SC
    Curr Opin Pharmacol; 2021 Feb; 56():85-92. PubMed ID: 33341460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
    Kumar R; Mehta P; Shankar KR; Rajora MAK; Mishra YK; Mostafavi E; Kaushik A
    Pharm Res; 2022 Nov; 39(11):2831-2855. PubMed ID: 35552983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management.
    Chopra H; Mohanta YK; Rauta PR; Ahmed R; Mahanta S; Mishra PK; Panda P; Rabaan AA; Alshehri AA; Othman B; Alshahrani MA; Alqahtani AS; Al Basha BA; Dhama K
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced diagnostic and therapeutic strategies in nanotechnology for lung cancer.
    Duan Y; Shen C; Zhang Y; Luo Y
    Front Oncol; 2022; 12():1031000. PubMed ID: 36568152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases.
    Andrade F; Rafael D; Videira M; Ferreira D; Sosnik A; Sarmento B
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1816-27. PubMed ID: 23932923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine as a promising strategy for the theranostics of infectious diseases.
    Liu H; Zhong W; Zhang X; Lin D; Wu J
    J Mater Chem B; 2021 Oct; 9(38):7878-7908. PubMed ID: 34611689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents.
    Kaur M; Guleria P; Kumar V
    Recent Pat Anticancer Drug Discov; 2022; 18(2):114-124. PubMed ID: 35770413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing Apoptosis in Lung Diseases using Nano-assisted Drug Delivery System.
    Shukla MK; Dubey A; Pandey S; Singh SK; Gupta G; Prasher P; Chellappan DK; Oliver BG; Kumar D; Dua K
    Curr Pharm Des; 2022; 28(39):3202-3211. PubMed ID: 35422206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
    Lim YH; Tiemann KM; Hunstad DA; Elsabahy M; Wooley KL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):842-871. PubMed ID: 27016134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart Nanotherapeutics and Lung Cancer.
    Doroudian M; Azhdari MH; Goodarzi N; O'Sullivan D; Donnelly SC
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections.
    Huang Z; Kłodzińska SN; Wan F; Nielsen HM
    Drug Deliv Transl Res; 2021 Aug; 11(4):1634-1654. PubMed ID: 33694082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis.
    Ibarra-Sánchez LÁ; Gámez-Méndez A; Martínez-Ruiz M; Nájera-Martínez EF; Morales-Flores BA; Melchor-Martínez EM; Sosa-Hernández JE; Parra-Saldívar R; Iqbal HMN
    J Drug Deliv Sci Technol; 2022 Apr; 70():103219. PubMed ID: 35280919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles for pulmonary drug delivery.
    García-Fernández A; Sancenón F; Martínez-Máñez R
    Adv Drug Deliv Rev; 2021 Oct; 177():113953. PubMed ID: 34474094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro- and nanocarrier-mediated lung targeting.
    Kurmi BD; Kayat J; Gajbhiye V; Tekade RK; Jain NK
    Expert Opin Drug Deliv; 2010 Jul; 7(7):781-94. PubMed ID: 20560777
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.